NECLIFENSENectar Lifesciences Limited· PharmaceuticalsLowNeutral
Announced Tue, 26 Aug · 12:12 IST

Nectar Lifesciences Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 29, 2025

Board & Shareholder Meetings View source PDF

NECLIFE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Nectar Lifesciences has called its 30th AGM for Monday, September 29, 2025 at 11:00 AM, to be conducted via video conferencing. Shareholders can vote electronically from September 26 (9:00 AM) to September 28 (5:00 PM), with a cut-off date of September 22, 2025. Key resolutions include adoption of FY25 standalone and consolidated financial statements, re-appointment of Chairman & Managing Director Sanjiv Goyal (who retires by rotation), ratification of cost auditor V. Kumar & Associates' remuneration at ₹2 lakh, and appointment of Mr. Prince Chadha (P. Chadha & Associates) as secretarial auditor for five years (FY26–FY30). A special resolution seeks adoption of a new set of Articles of Association, triggered by private equity investor Isengard Direct PE LLC fully exiting the company by December 2024. Sanjiv Goyal holds roughly 44.35% of the paid-up capital (24.90% direct plus 19.45% as Karta of Sanjiv HUF).

Likely market impact

This is a routine governance filing with standard items (financials adoption, director re-appointment, auditor ratifications). The Articles amendment simply cleans up rights tied to the now-exited PE investor and carries no operational impact, so shareholders should mainly focus on reviewing and voting during the e-voting window.